Outcome of Board Meeting- Dividend
ANTHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.4 pts less than Nifty Midcap 150 and 0.4 pts less than its Pharmaceuticals & Biotechnology peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Anthem Biosciences Board meeting on May 19, 2026 approved FY2026 audited results with standalone net profit of INR 903.07 million and consolidated net profit of INR 590.23 million. The Board recommended a final dividend of INR 2.00 per equity share (100% of face value) for FY2026, subject to shareholder approval at the 20th AGM on July 22, 2026. Record date for dividend is June 26, 2026. The company also allotted 14,81,250 equity shares under the ESOP 2024 scheme, increasing paid-up capital to INR 1,12,63,90,202. This is Anthem Biosciences' first dividend announcement post-IPO (listed July 2025).
The 100% dividend payout on INR 2 face value signals strong cash generation and management confidence. For new shareholders, this represents a direct cash return, though the yield percentage depends on the current market price.